Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new revision of the page metadata.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s revision/build version has been updated from **v3.5.2** to **v3.5.3**. This reflects a platform or documentation version change rather than a change to the study information.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision: v3.4.2 appears on the page; no changes to study details, eligibility criteria, or outcome measures are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.